Please login to the form below
Pfizer/BioNTech
This page shows the latest Pfizer/BioNTech news and features for those working in and with pharma, biotech and healthcare.
Alliance for mRNA Medicines launched to accelerate global innovation
Founding members of the organisation include BioNTech, CSL, CureVac, Ginkgo Bioworks, Ethris, Johns Hopkins University, Mayo Clinic, Replicate Bioscience and Verve Therapeutics. ... The potential of the approach was brought to the fore during the
Latest news
-
Pfizer and BioNTech’s COVID-19/flu combination vaccine shows promise in phase 1/2 study
Pfizer and BioNTech have announced positive topline results from an ongoing phase 1/2 study of their mRNA-based combination vaccine for influenza and COVID-19 and outlined plans to enter ... world,” said Annaliesa Anderson, senior vice president and
-
Nobel Prize in Medicine awarded to pair of scientists behind mRNA COVID-19 vaccines
mRNA vaccines, including those from Moderna and Pfizer/BioNTech, have now been used globally to protect against severe COVID-19.
-
Moderna’s XBB.1.5-adapted COVID-19 vaccine receives MHRA approval
The approval comes shortly after Pfizer/BioNTech’s XBB.1.5-adapted COVID-19 vaccine received approval from the UK regulator, also for use in those aged six months and older. ... Pfizer/BioNTech’s updated vaccine is also approved in the EU, and
-
US CDC recommends updated COVID-19 vaccines for autumn/winter season
Pfizer/BioNTech and Moderna’s updated vaccines will be available in the coming days. ... The recommendation comes after the US Food and Drug Administration (FDA) approved updated COVID-19 vaccines from Pfizer/BioNTech and Moderna, which will be
-
FDA approves Pfizer/BioNTech and Moderna’s updated COVID-19 vaccines
The US Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Pfizer/BioNTech and Moderna to more closely target currently circulating variants. ... Pfizer/BioNTech and Moderna have said their updated vaccines are expected to be
More from news
Approximately 108 fully matching, plus 157 partially matching documents found.
Latest Intelligence
-
Turning the UK into an mRNA superpower: what would it take?
The country had successes in accelerating COVID-19 vaccines. It was the first in the world to administer the Pfizer-BioNTech vaccine outside a clinical trial, while Oxford University helped develop ... It has also signed strategic partnerships with
-
FlyPharma Europe unites pharma, biotech and bio pharma with air cargo logistics
Pfizer/BioNTech vaccines are stored in specialised conditions in a fill-and-finish facility in Halle, Saxony- Anhalt.
-
Rare genetic diseases – what’s in store for 2021?
In the UK, the looming Brexit sparked new models of regulatory approval and fast-track opportunities, as recently observed in the rapid approval of Pfizer’s COVID-19 vaccine. ... So far the Pfizer/BioNTech, Moderna and AstraZeneca/Oxford University
-
Working together against COVID-19
Beyond the connection between HCPs and pharma or NGOs, it is encouraging to see collaborations such as Clover and GSK evaluating a vaccine candidate and Pfizer and Biontech doing the same. ... A number of top pharma companies are included in the newly
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
There's power in collaboration
Just look at the success of the Covid-19 vaccine development… from the collaboration between AstraZeneca, Oxford University and it’s Vaccitech company to the partnership between BioNTech, Fosun Pharma and ... Pfizer, the fastest development of a
-
What does the future hold for clinical trial recruitment?
This work is ongoing as the virus mutates; last month, it was announced that Pfizer and BioNTech had started clinical trials for a new Covid vaccine targeting the Omicron variant.
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
In the past year, we have seen partnerships between companies such as Pfizer and BioNTech; Oxford University and AstraZeneca and more recently GSK and CureVac. ... doi:10.1136/bmj.n129. 24. Dean G, Reuters. The UK approved Pfizer’s vaccine too quickly
-
What does the COVID-19 vaccine mean for the future of R&D?
Both the Oxford/AstraZeneca and Pfizer/BioNTech vaccines were developed using platform technologies which didn’t exist 20 years ago, allowing these vaccines to be developed much faster.
-
The UK has approved the first vaccine for COVID-19. What now?
The authorisation of Pfizer/BioNtech's mRNA vaccine by the MHRA is great news, but no-one has ever tried to roll out a vaccine as rapidly as this one, so
More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.
Subscribe to our email news alerts
- Pfizer’s RSV vaccine granted MHRA approval to protect infants and older adults
- Novavax’s updated COVID-19 vaccine granted Emergency Use Listing by WHO
- FDA to investigate risk of T-cell malignancy from CAR-T cell immunotherapies
- Boehringer Ingelheim and IBM announce AI antibody drug discovery partnership
- New blood test to reduce heart attacks and death rates in A&E heart patients
- Clairvoyant commercialisation
No results were found
PMHub
Medscape Medical Affairs
Medscape Medical Affairs enables all medical affairs professionals to take a more strategic leadership role, and maximize the impact of...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
